They actually don't need the money or at least don't have any imminent need if they do not go big on R&D and on the Xprecia FDA trials for self testing in the near term. My suspicion is that they might look to pull the whole CR for now and maybe, with the FDA approval now secure, look at finding a debt facility and revisit a CR to fund the "new" growth some point down the line. I think would be positive for the share price if they did this.
Ann: FDA Approval for Xprecia Prime, page-54
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add UBI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
15.5¢ |
Change
0.005(3.33%) |
Mkt cap ! $46.20M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.5¢ | 15.0¢ | $12.37K | 82.50K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 67721 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.5¢ | 95947 | 1 |
View Market Depth
| Last trade - 15.58pm 03/07/2024 (20 minute delay) ? |
| UBI (ASX) Chart |